These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 12559173)
1. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Montaner S; Sodhi A; Molinolo A; Bugge TH; Sawai ET; He Y; Li Y; Ray PE; Gutkind JS Cancer Cell; 2003 Jan; 3(1):23-36. PubMed ID: 12559173 [TBL] [Abstract][Full Text] [Related]
2. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis? Sodhi A; Montaner S; Gutkind JS FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988 [TBL] [Abstract][Full Text] [Related]
3. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229 [TBL] [Abstract][Full Text] [Related]
4. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. Yang TY; Chen SC; Leach MW; Manfra D; Homey B; Wiekowski M; Sullivan L; Jenh CH; Narula SK; Chensue SW; Lira SA J Exp Med; 2000 Feb; 191(3):445-54. PubMed ID: 10662790 [TBL] [Abstract][Full Text] [Related]
5. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia. Martin D; Galisteo R; Ji Y; Montaner S; Gutkind JS Oncogene; 2008 Mar; 27(13):1844-52. PubMed ID: 17934524 [TBL] [Abstract][Full Text] [Related]
6. A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis. Ma Q; Cavallin LE; Leung HJ; Chiozzini C; Goldschmidt-Clermont PJ; Mesri EA Antioxid Redox Signal; 2013 Jan; 18(1):80-90. PubMed ID: 22746102 [TBL] [Abstract][Full Text] [Related]
7. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Sodhi A; Chaisuparat R; Hu J; Ramsdell AK; Manning BD; Sausville EA; Sawai ET; Molinolo A; Gutkind JS; Montaner S Cancer Cell; 2006 Aug; 10(2):133-43. PubMed ID: 16904612 [TBL] [Abstract][Full Text] [Related]
8. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene. Martin D; Nguyen Q; Molinolo A; Gutkind JS Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663 [TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Bais C; Van Geelen A; Eroles P; Mutlu A; Chiozzini C; Dias S; Silverstein RL; Rafii S; Mesri EA Cancer Cell; 2003 Feb; 3(2):131-43. PubMed ID: 12620408 [TBL] [Abstract][Full Text] [Related]
10. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma. Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770 [TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus vFLIP promotes MEndT to generate hybrid M/E state for tumorigenesis. Chen W; Ding Y; Liu D; Lu Z; Wang Y; Yuan Y PLoS Pathog; 2021 Dec; 17(12):e1009600. PubMed ID: 34936683 [TBL] [Abstract][Full Text] [Related]
13. Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma. Montaner S Cell Cycle; 2007 Feb; 6(4):438-43. PubMed ID: 17329974 [TBL] [Abstract][Full Text] [Related]
14. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma. Medina MV; D Agostino A; Ma Q; Eroles P; Cavallin L; Chiozzini C; Sapochnik D; Cymeryng C; Hyjek E; Cesarman E; Naipauer J; Mesri EA; Coso OA PLoS Pathog; 2020 Oct; 16(10):e1009006. PubMed ID: 33057440 [TBL] [Abstract][Full Text] [Related]
15. Glycosylation of KSHV encoded vGPCR functions in its signaling and tumorigenicity. Wu H; Liu L; Xiao J; Chi M; Qu Y; Feng H Viruses; 2015 Mar; 7(4):1627-41. PubMed ID: 25835533 [TBL] [Abstract][Full Text] [Related]
16. Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. Gutierrez KD; Morris VA; Wu D; Barcy S; Lagunoff M J Virol; 2013 Jun; 87(12):6758-68. PubMed ID: 23552426 [TBL] [Abstract][Full Text] [Related]
17. Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma. Jham BC; Ma T; Hu J; Chaisuparat R; Friedman ER; Pandolfi PP; Schneider A; Sodhi A; Montaner S PLoS One; 2011 Apr; 6(4):e19103. PubMed ID: 21559457 [TBL] [Abstract][Full Text] [Related]
18. KSHV non-structural membrane proteins involved in the activation of intracellular signaling pathways and the pathogenesis of Kaposi's sarcoma. Abere B; Schulz TF Curr Opin Virol; 2016 Oct; 20():11-19. PubMed ID: 27518127 [TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Vart RJ; Nikitenko LL; Lagos D; Trotter MW; Cannon M; Bourboulia D; Gratrix F; Takeuchi Y; Boshoff C Cancer Res; 2007 May; 67(9):4042-51. PubMed ID: 17483315 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation. Zhang X; Wang JF; Kunos G; Groopman JE Cancer Res; 2007 Aug; 67(15):7230-7. PubMed ID: 17671191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]